Detalles de la búsqueda
1.
Preliminary safety assessment of CIGB-210, an investigational peptide for HIV infection.
Hum Exp Toxicol
; 41: 9603271211073708, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35112887
2.
E2-CD154 vaccine candidate is safe and immunogenic in pregnant sows, and the maternal derived neutralizing antibodies protect piglets from classical swine fever virus challenge.
Vet Microbiol
; 260: 109153, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-34271304
3.
Dengue encephalitis-associated immunopathology in the mouse model: Implications for vaccine developers and antigens inducer of cellular immune response.
Immunol Lett
; 176: 51-6, 2016 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-27233365
4.
APL-2, an altered peptide ligand derived from heat-shock protein 60, induces interleukin-10 in peripheral blood mononuclear cell derived from juvenile idiopathic arthritis patients and downregulates the inflammatory response in collagen-induced arthritis model.
Clin Exp Med
; 15(1): 31-9, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24474501
5.
CIGB-247: a VEGF-based therapeutic vaccine that reduces experimental and spontaneous lung metastasis of C57Bl/6 and BALB/c mouse tumors.
Vaccine
; 30(10): 1790-9, 2012 Feb 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-22240345
6.
Antigen dose escalation study of a VEGF-based therapeutic cancer vaccine in non human primates.
Vaccine
; 30(2): 368-77, 2012 Jan 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-22075086
7.
Immunogenicity and some safety features of a VEGF-based cancer therapeutic vaccine in rats, rabbits and non-human primates.
Vaccine
; 28(19): 3453-61, 2010 Apr 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-20197134
Resultados
1 -
7
de 7
1
Próxima >
>>